GSK, FDA warn doctors against dissolving Relenza

10/11/2009 | MarketWatch

The FDA and GlaxoSmithKline warned doctors that antiviral drug Relenza should not be administered with a nebulizer or ventilator, or "reconstituted in any liquid formulation." Relenza, which is sometimes dissolved for patients who cannot take oral medications, reportedly caused the death of an influenza patient who received the drug through a mechanical ventilator.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ